Filtros de búsqueda

Lista de obras de

"Comment on a retraction": author response.

artículo científico publicado en 2009

A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.

artículo científico publicado en 2008

A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's disease.

artículo científico publicado en 2015

A positive breath hydrogen test does not predict the occurrence of a spontaneous bacterial peritonitis in cirrhotic patients with ascites

artículo científico publicado en 2009

Abdominal necrotic abscess from colonic fistula treated endoscopically.

artículo científico publicado en 2015

Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis.

artículo científico publicado en 2016

Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease

scientific article published on 01 February 2015

Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study

scientific article published on 01 January 2019

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

artículo científico publicado en 2017

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months.

artículo científico publicado en 2016

Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's Disease

scientific article published on 28 April 2019

Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course

artículo científico publicado en 2015

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.

artículo científico publicado en 2017

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab is associated with a profound long-lasting depletion of Foxp3+ regulatory T cells: a mechanistic explanation for ipilimumab-induced severe enterocolitis?

artículo científico publicado en 2011

Butyrate strongly inhibits in vitro stimulated release of cytokines in blood.

artículo científico publicado en 2002

CD4+ T cells and Lactobacillus casei control relapsing colitis mediated by CD8+ T cells.

artículo científico publicado en 2009

Chronic active ulcerative colitis. Efficacy of intravenous followed by oral cyclosporine combined with azathioprine

artículo científico publicado en 2004

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

artículo científico publicado en 2016

Colon cancer in inflammatory bowel disease: recent trends, questions and answers.

artículo científico publicado en 2009

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

artículo científico publicado en 2017

Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study

scientific article published on 22 March 2020

Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational Study

scientific article published on 01 August 2019

Concentrations of Ustekinumab During Induction Therapy Associate With Remission in Patients With Crohn's Disease

artículo científico publicado en 2019

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

artículo científico publicado en 2016

Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.

artículo científico publicado en 2017

Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study

artículo científico publicado en 2017

Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study

scientific article published on 08 November 2018

Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study.

artículo científico publicado en 2018

Effective use of argon plasma coagulation in the treatment of severe radiation proctitis.

artículo científico publicado en 2001

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

scientific article published on 14 April 2020

Effects of local corticosteroids on acute experimental urticaria.

artículo científico publicado en 2004

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis

scientific article published on 10 September 2018

Efficacy and Safety of Infliximab Tolerance Induction in Patients with Inflammatory Bowel Diseases who Experienced Acute Infusion Reactions

artículo científico publicado en 2018

Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.

artículo científico publicado en 2015

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

scientific article published on 13 June 2019

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

artículo científico publicado en 2017

Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experience.

artículo científico publicado en 2015

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients

artículo científico publicado en 2016

Endoscopic and histologic characteristics of serrated lesions

artículo científico publicado en 2015

Enrichment of Circulating and Mucosal Cytotoxic CD8+ T Cells Is Associated with Postoperative Endoscopic Recurrence in Patients with Crohn's Disease

artículo científico publicado en 2015

Evolution of reimbursement of high-cost anticancer drugs: Financial impact within a university hospital

artículo científico publicado en 2017

Faecal bacterial mass and energetic losses in healthy humans and patients with a short bowel syndrome

scientific article published on 23 August 2006

Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature

artículo científico publicado en 2017

Frequency and severity of ileal adenomas in familial adenomatous polyposis after colectomy.

artículo científico publicado en 2007

Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells.

artículo científico publicado en 2016

IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease

artículo científico publicado en 2018

Identification of Mycobacterium cosmeticum sp. as a novel colitogenic infectious agent in a nonimmunocompromised patient

artículo científico publicado en 2011

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience

artículo científico publicado en 2013

Infliximab for refractory ulcerative proctitis

scientific article published on 08 March 2010

Infliximab treatment does not induce organ-specific or nonorgan-specific autoantibodies other than antinuclear and anti-double-stranded DNA autoantibodies in Crohn's disease

artículo científico publicado en 2005

Is scintigraphic double-track appearance a sign of severe acute episodes of ulcerative colitis?

artículo científico publicado en 2004

Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?

artículo científico publicado en 2018

Isolated ileitis associated with primary sclerosing cholangitis in three patients with Crohn's disease

artículo científico publicado en 2016

Ketoprofen-induced acute hepatitis

artículo científico publicado el 1 de junio de 2001

Laparoscopic total colectomy: Does the indication influence the outcome?

artículo científico publicado en 2011

Letter: extracorporeal photopheresis in refractory chronic active ulcerative colitis

scientific article published on 01 August 2013

Letter: mucosal healing in ulcerative colitis – higher relevance than in Crohn's disease? Authors' reply ⬇️

artículo científico publicado el 1 de julio de 2013

Letter: thiopurines - is less really more? Authors' reply

artículo científico publicado en 2018

Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease

scientific article published on 17 March 2015

Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: a report of 2 cases

artículo científico publicado en 2010

Long-term disease course in a patient with severe neonatal IPEX syndrome

artículo científico publicado en 2015

Multiple and fulminant cutaneous squamous cell carcinomas in a Crohn's disease patient treated with immunosuppressants and adalimumab

artículo científico publicado en 2010

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort

artículo científico publicado en 2016

Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases ⬇️

artículo científico publicado el 1 de abril de 2013

Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

artículo científico publicado en 2019

Pancytopenia induced by two low-dose injections of methotrexate in a patient treated for ulcerative colitis

artículo científico publicado en 2007

Predictive Models of Therapeutic Response to Vedolizumab: A Novel Step into Personalized Medicine in Crohn's Disease?

artículo científico publicado en 2018

Prevalence of Species in the Ileum of Crohn's Disease Patients and Controls

artículo científico publicado en 2018

Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease

scientific article published on 29 May 2019

Response to Dai et al

artículo científico publicado en 2015

Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis

artículo científico publicado en 2017

Segmentary infarct of the greater omentum: a rare cause of acute abdomen

artículo científico publicado en 2003

Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity

scientific article published on 05 June 2007

Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept Study

artículo científico publicado en 2018

Specific carbohydrate malabsorption

artículo científico publicado en 2001

T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence

scientific article published on 12 February 2019

Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.

artículo científico

Therapy with anti-TNFα antibody enhances number and function of Foxp3+ regulatory T cells in inflammatory bowel diseases

artículo científico publicado el 1 de enero de 2011

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

artículo científico publicado en 2019

Transcutaneous posterior tibial nerve stimulation for fecal incontinence in inflammatory bowel disease patients: a therapeutic option?

artículo científico publicado en 2009

Urinary neopterin is a valuable tool in monitoring Crohn's disease activity.

artículo científico publicado en 2008

Usefulness of confocal laser endomicroscopy for predicting postoperative recurrence in patients with Crohn's disease: a pilot study

artículo científico publicado en 2019

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

artículo científico publicado en 2019

[Angioneurotic edema]

artículo científico publicado en 2001

[Cancer and inflammatory bowel diseases]

scientific article published on 01 March 2003

[Colonic microflora and cancer]

artículo científico publicado en 2001

[Granulomatous arteritis through sarcoidosis]

artículo científico publicado en 2002

[Non-invasive follow up of patients with inflammatory bowel diseases]

artículo científico publicado en 2014

[Reactivation of hepatitis B after cessation of Rituximab monotherapy]

artículo científico publicado en 2006

[Ulcerative colitis and anti-TNFalpha]

scientific article published on 01 January 2007

[Vaccine-induced urticaria: how to differentiate allergy (IgE) from pseudoallergy?]

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda